Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
NCT ID: NCT00281411
Last Updated: 2018-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2001-03-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients. The advantages of MRA with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
NCT05349084
Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry
NCT02805621
PET-CT After Nellix Implantation
NCT02349100
Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA
NCT05199792
Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease
NCT00296855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computed Tomography Angiography
Computed Tomography Angiography
Magnetic Resonance Angiography
Magnetic Resonance Angiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* claustrophobia
* pacemaker
* other non-MRI compatible implants
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Research Office Imaging Division
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clinical Research Office Imaging Division
Clinical research coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
W. Mali, MD PhD
Role: PRINCIPAL_INVESTIGATOR
UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMC Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC.2005.01.291E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.